Search clinical trials for: Direct oral anticoagulant (DOAC)

Total 495 results

Bayer

Completed

An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres (SILVER-AP)

Stroke | Atrial Fibrillation | Prevention and Control

Spain
Bayer

Completed

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers (BRONCE-AP)

Stroke | Atrial Fibrillation | Prevention and Control

Spain
Janssen Research & Development, LLC

Completed

A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants

Uterine Hemorrhage

United States
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs Warfarin)

Myocardial Infarction | Ischemic Stroke | Atrial Fibrillation | All-cause Mortality | Systemic Embolization | Major Bleed

Canada
Peking Union Medical College Hospital

Recruiting

Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients

Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding

China
Takeshi Morimoto
Bayer Yakuhin, Ltd.

Active, not recruiting

Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer (ONCO PE)

Neoplasms | Venous Thrombosis | Anticoagulants

Japan
Bayer

Completed

A Study to Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention. (BELANCE)

Non-Valvular Atrial Fibrillation

Belgium
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Mild Head Injury, Antiplatelets, and Anticoagulants

Craniocerebral Trauma | Cerebral Hemorrhage

Italy
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation (REACT-AF)

Atrial Fibrillation

United States
University Hospital, Brest
University Hospital of Saint-Etienne

Completed

REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. (RENOVE)

Venous Thromboembolism

France
Ajou University School of Medicine

Active, not recruiting

Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation (Paradox)

Obesity | Atrial Fibrillation | Prognosis | Anticoagulants

Korea, Republic of
Biotronik, Inc.

Terminated

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk (IMPACT)

Stroke | Atrial Fibrillation | Atrial Flutter | Major Bleeding | Embolism, Systemic Arterial

United States, Canada, United Kingdom, Denmark, Germany, Australia
Quovadis Associazione

Recruiting

MAC Project, Monitoring of AntiCoagulant Therapies (MAC) (MAC)

Anticoagulants and Bleeding Disorders

Italy
University College, London

Recruiting

OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial (OPTIMAS)

Atrial Fibrillation | Stroke, Acute

United Kingdom
Boston Scientific Corporation

Active, not recruiting

CHAMPION-AF Clinical Trial (CHAMPION-AF)

Stroke | Atrial Fibrillation | Bleeding

United States, Australia, Denmark, Canada, Israel, United Kingdom, France, Belgium, Netherlands, Japan, Germany, Switzerland, Italy, Poland, Saudi Arabia, Spain
Haemonetics Corporation

Completed

Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System

DOAC Eligible Subjects

United States
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Per-procedural Concentration of Direct Oral Anticoagulants (CORIDA)

Per-procedural Concentrations of Oral Anticoagulants

France
Boehringer Ingelheim

Completed

Health-related Quality of Life in Patients on Anticoagulants (RE-QUOL)

Atrial Fibrillation

Spain
InCor Heart Institute

Recruiting

Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial (SILENT)

Atrial Fibrillation

Brazil
Cedars-Sinai Medical Center
National Institute on Aging (NIA)

Recruiting

A Trial of Pharmacist Management of Oral Anticoagulation THerapy Versus Enhanced Usual CARe in the communitY for AF (APOTHECARYAF)

Stroke | Atrial Fibrillation

United States
Hospital Universitario La Fe

Recruiting

Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures (DOAC-NOSTOP)

Coronary Artery Disease | Bleeding | Direct Acting Anticoagulant Adverse Reaction

Spain, Italy
McMaster University
St. Joseph's Healthcare Hamilton; Hamilton Health Sciences Corporation

Unknown

Perioperative Anticoagulant Use for Surgery Evaluation Study Part 2 Pilot (PAUSE2rctP)

Atrial Fibrillation

Canada
Sunnybrook Health Sciences Centre

Recruiting

Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma (ATTAACH)

Atrial Fibrillation | Subdural Hematoma

Canada
Yong Seog Oh

Unknown

Anticoagulation After RFCA (Reducible)

Atrial Fibrillation

Korea, Republic of
Azienda Ospedaliera Città della Salute e della...

Unknown

CHAOS Registry Study (CHAOS)

Atrial Fibrillation | Oral Anticoagulants | Ischem Heart Disease | Primary Coronay Intervention

Italy
Yale University

Completed

The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants

Pleural Effusion | Thoracic Effusion

United States
Cliniques universitaires Saint-Luc- Université...

Completed

Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants (ADR-OAC)

Hemorrhage | Embolism and Thrombosis

Belgium
Yonsei University

Unknown

Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation

Atrial Fibrillation

Korea, Republic of
Suleyman Demirel University

Active, not recruiting

Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation (AFTER-CV)

Atrial Fibrillation | Cardioversion | Cerebrovascular Stroke

Turkey
Assiut University

Recruiting

Obesity Paradox in Non Valvular Atrial Fibrillation Regarding Outcomes: Fact or Fiction

Obesity Paradox

Egypt
Boehringer Ingelheim

Completed

This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain (RE-CONOCE)

Atrial Fibrillation

Spain
Assistance Publique Hopitaux De Marseille

Completed

Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients

Atrial Fibrillation
Chinese University of Hong Kong

Recruiting

Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients (NOAC-GAP)

Upper Gastrointestinal Bleeding

Singapore, Hong Kong, Australia
Academisch Medisch Centrum - Universiteit van Amsterdam...
Sahlgrenska University Hospital, Sweden; University of Helsinki; Hospital de...

Recruiting

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis (DOAC-CVT)

Cerebral Venous Thrombosis

Netherlands
Uppsala University
The Swedish Stroke Register (Riksstroke)

Active, not recruiting

TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation

Ischemic Stroke | Atrial Fibrillation

Sweden
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers

Atrial Fibrillation | Thromboembolism, Venous

Italy
Region Örebro County

Completed

Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County

Atrial Fibrillation | Stroke, Ischemic

Sweden
Hospital Sirio-Libanes
Daiichi Sankyo

Not yet recruiting

Vitamin K AntagonISt, Factor Xa Inhibitor Or Nothing In Atrial Fibrillation And DIalytic End-stage Renal DiseasE (VISIONAIRE) (VISIONAIRE)

Chronic Kidney Diseases | Atrium; Fibrillation
Boehringer Ingelheim

Completed

This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain

Atrial Fibrillation

Spain
China National Center for Cardiovascular Diseases

Not yet recruiting

LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.

Non-paroxysmal Atrial Fibrillation

China
Bayer

Completed

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort (OSCAR-US)

Treatment of Venous Thromboembolism in Cancer Patients | Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients

United States
Abbott Medical Devices

Recruiting

Amplatzer Amulet LAAO vs. NOAC (CATALYST)

Stroke | Atrial Fibrillation | Bleeding

United States, Australia, Netherlands, Denmark, Spain, Poland, France, Hong Kong, Switzerland, Germany, Japan, Czechia, Canada, Italy, United Kingdom, Lithuania
Hôpital NOVO

Recruiting

Assessment of a Procedure for Managing Oral Anticoagulants (NACO) in the Management of Fractures (STOP-NACO)

Femur Fracture

France
Rabin Medical Center
Pfizer

Unknown

Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation

Atrial Fibrillation and Flutter

Israel
Danderyd Hospital
Karolinska Institutet

Terminated

Screening for Atrial Fibrillation in Pulmonary Embolism Study -SAFE-PE Study (SAFE-PE)

Atrial Fibrillation | Pulmonary Embolism

Sweden
Centre Hospitalier Universitaire de Nīmes

Recruiting

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus (ARGONAUT)

Heart Failure | STEMI | Intracardiac Thrombus

France, Réunion
Groupe Maladies hémorragiques de Bretagne

Completed

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia (KADOAH)

Hemophilia A | Hemophilia B | Anticoagulant-induced Bleeding

France
Marshall University

Unknown

Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) (HIT)

Heparin-induced Thrombocytopenia

United States
Charles University, Czech Republic
Ministry of Health, Czech Republic

Completed

Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation (PRAGUE-17)

Atrial Fibrillation

Czechia
Assistance Publique - Hôpitaux de Paris

Unknown

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF) (Presage-Aco)

Non Valvular Atrial Fibrillation (nv AF)

Search clinical trials for: Direct oral anticoagulant (DOAC)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations